An optical device

US2017274221A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2017274221-A1
Application numberUS-201515508542-A
CountryUS
Kind codeA1
Filing dateSep 2, 2015
Priority dateSep 3, 2014
Publication dateSep 28, 2017
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An optical device including an optical substrate providing with an optical filter configured to inhibit transmission of harmful UV and/or blue light wherein the optical device is further configured to allow retinal exposure of an eye to at least one selected range of wavelengths of light in the visible spectrum of 460 nm to 560 nm, preferably of 480 nm to 520 nm.

First claim

Opening claim text (preview).

1 . An optical device comprising an optical substrate providing with an optical spectral filter configured to inhibit transmission of harmful UV and/or blue light wherein the optical device is further configured to allow retinal exposure of an eye to at least one selected range of wavelengths of light in the visible spectrum of 460 nm to 560 nm, preferably of 480 nm to 520 nm. 2 . The optical device according to claim 1 , wherein the optical filter is configured to allow transmission in the visible spectrum outside the selected range of wavelengths at visual transmittance rate of 3% to 43% depending on the level of solar protection required. 3 . The optical device according to claim 1 , wherein the at least one selected range of wavelengths of light is one selected range of wavelengths centered on a wavelength within the range 480 nm to 510 nm. 4 . The optical device according to claim 3 , wherein the at least one selected range of wavelengths of light is one selected range of wavelengths with a bandwidth in a range from 30 nm to 70 nm. 5 . The optical device according to claim 1 , wherein the optical filter is configured to selectively inhibit transmission of wavelengths of incident light within the range 380 nm to 455 nm, preferably 415 nm to 455 nm, at an inhibition rate within the range 20% to 100%, preferably 60 to 100%. 6 . The optical device according to claim 1 , wherein the optical filter is configured to selectively transmit light within the at least one selected range of wavelengths of light with an average light transmittance value greater than or equal to 50% and preferably, greater than 95% and more preferably equal to 100%. 7 . The optical device according to claim 6 , wherein the optical filter comprises at least one dye and/or one pigment configured to allow transmission of the at least one selected range of wavelengths of light. 8 . The optical device according to claim 6 , wherein the optical filter comprises interferential filtering means configured to allow transmission of the at least one selected range of wavelengths of light. 9 . The optical device according to claim 1 wherein the optical filter is further configured to selectively transmit light within the range 560 nm to 600 nm with an average light transmittance value greater than or equal to 50% and preferably equal to 100%. 10 . A method for preventing or treating chronobiological disorders, comprising exposing an eye of a subject in need thereof to at least one selected range of wavelengths of light in the visible spectrum of 460 nm to 560 nm provided by the optical device of claim 1 . 11 . A method for controlling the constriction of the pupil of the eye, comprising exposing an eye of a subject in need thereof to at least one selected range of wavelengths of light in the visible spectrum of 460 nm to 560 nm provided by the optical device of claim 1 . 12 . The optical device according to claim 1 , wherein the optical device is an optical lens selected among the list of ophthalmic lens, semi-finished lens, contact lens, intraocular lens.

Assignees

Inventors

Classifications

  • Visible light · CPC title

  • G02C7/10Primary

    Filters, e.g. for facilitating adaptation of the eyes to the dark; Sunglasses · CPC title

  • Optical elements and systems for visual disorders other than refractive errors, low vision · CPC title

  • comprising deposited thin solid films (G02B5/281 - G02B5/289 take precedence; multilayered film filters for fibre optic multiplexing G02B6/29361) · CPC title

  • Absorbing filters {(G02B5/201 - G02B5/208 take precedence)} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2017274221A1 cover?
An optical device including an optical substrate providing with an optical filter configured to inhibit transmission of harmful UV and/or blue light wherein the optical device is further configured to allow retinal exposure of an eye to at least one selected range of wavelengths of light in the visible spectrum of 460 nm to 560 nm, preferably of 480 nm to 520 nm.
Who is the assignee on this patent?
Essilor Int
What technology area does this patent fall under?
Primary CPC classification G02C7/10. Mapped technology areas include Physics.
When was this patent published?
Publication date Thu Sep 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).